Skip to main content
Huberman Lab

Mushrooms for the Mind & Immune System | Paul Stamets

148 min episode · 3 min read
·
Paul Stamets

Episode

148 min

Read time

3 min

Topics

Productivity, Health & Wellness, Relationships

AI-Generated Summary

Key Takeaways

  • ✓Vaccine Enhancement via Mushroom Mycelium: A double-blind placebo-controlled clinical trial of 90 participants found that taking Agaricon and Turkey Tail mycelium for four days alongside Pfizer or Moderna mRNA vaccines produced triple the antibody levels six months later compared to vaccine-only controls. It also produced a statistically significant reduction in 10 common vaccine side effects, suggesting mycelium can decouple immunogenicity from reactogenicity — boosting protection while reducing adverse reactions simultaneously.
  • ✓Infection Duration Reduction: In a 50-person COVID trial, unvaccinated participants who took Agaricon and Turkey Tail mycelium reached 50% symptom resolution 5.1 days sooner than placebo. Vaccinated participants who still contracted COVID resolved symptoms 0.9 days sooner. For context, Tamiflu reduces symptom duration by approximately one day. The mycelium also significantly reduced coughing and sneezing — two primary transmission vectors — suggesting a public health benefit beyond individual recovery.
  • ✓Anti-Inflammatory Immune Modulation: Mycelium grown on rice creates a fermented product that simultaneously stimulates interleukin-10 and interleukin-1Ra, both anti-inflammatory cytokines. This dual action — upregulating immune readiness while suppressing cytokine storm risk — addresses the primary concern the FDA raised during COVID research: that immune stimulants could accelerate death via hyperinflammation. This mechanism distinguishes mycelium-on-rice from standard mushroom fruit bodies or isolated mycelium.
  • ✓Psilocybin Dosing Framework: Clinical trials use 25mg of pure psilocybin as the standard therapeutic dose, equivalent to 2.5 grams of dried Psilocybe cubensis mushrooms at 1% psilocybin concentration. A microdose is subsensorium — typically 1–3mg of pure psilocybin or roughly 0.1 grams of mushroom. A "museum dose" sits around 0.5 grams of mushroom (5mg psilocybin). A heroic dose begins at 2.5 grams and reaches 4–5 grams, requiring therapeutic support before, during, and after the session.
  • ✓Psilocybin Neuroplasticity and Addiction: Psilocybin promotes synaptogenesis by stimulating dendritic spine growth from axon tips, forming new neural pathways that can interrupt entrenched addictive or compulsive behavioral loops. In tobacco cessation studies, two heroic doses of psilocybin produced a 90% non-smoking rate at one year — far exceeding nicotine patch outcomes. The compound also shows statistically significant associations with reduced partner violence and crime following a single dose, based on observational data.

What It Covers

Mycologist Paul Stamets joins Andrew Huberman to examine how specific fungi — particularly Agaricon and Turkey Tail mycelium — bolster immune function, enhance vaccine efficacy, and reduce infection duration. The conversation also covers psilocybin's clinical applications for depression, OCD, and addiction, plus microdosing protocols, neuroplasticity mechanisms, and pandemic preparedness through natural immunity upregulation.

Key Questions Answered

  • •Vaccine Enhancement via Mushroom Mycelium: A double-blind placebo-controlled clinical trial of 90 participants found that taking Agaricon and Turkey Tail mycelium for four days alongside Pfizer or Moderna mRNA vaccines produced triple the antibody levels six months later compared to vaccine-only controls. It also produced a statistically significant reduction in 10 common vaccine side effects, suggesting mycelium can decouple immunogenicity from reactogenicity — boosting protection while reducing adverse reactions simultaneously.
  • •Infection Duration Reduction: In a 50-person COVID trial, unvaccinated participants who took Agaricon and Turkey Tail mycelium reached 50% symptom resolution 5.1 days sooner than placebo. Vaccinated participants who still contracted COVID resolved symptoms 0.9 days sooner. For context, Tamiflu reduces symptom duration by approximately one day. The mycelium also significantly reduced coughing and sneezing — two primary transmission vectors — suggesting a public health benefit beyond individual recovery.
  • •Anti-Inflammatory Immune Modulation: Mycelium grown on rice creates a fermented product that simultaneously stimulates interleukin-10 and interleukin-1Ra, both anti-inflammatory cytokines. This dual action — upregulating immune readiness while suppressing cytokine storm risk — addresses the primary concern the FDA raised during COVID research: that immune stimulants could accelerate death via hyperinflammation. This mechanism distinguishes mycelium-on-rice from standard mushroom fruit bodies or isolated mycelium.
  • •Psilocybin Dosing Framework: Clinical trials use 25mg of pure psilocybin as the standard therapeutic dose, equivalent to 2.5 grams of dried Psilocybe cubensis mushrooms at 1% psilocybin concentration. A microdose is subsensorium — typically 1–3mg of pure psilocybin or roughly 0.1 grams of mushroom. A "museum dose" sits around 0.5 grams of mushroom (5mg psilocybin). A heroic dose begins at 2.5 grams and reaches 4–5 grams, requiring therapeutic support before, during, and after the session.
  • •Psilocybin Neuroplasticity and Addiction: Psilocybin promotes synaptogenesis by stimulating dendritic spine growth from axon tips, forming new neural pathways that can interrupt entrenched addictive or compulsive behavioral loops. In tobacco cessation studies, two heroic doses of psilocybin produced a 90% non-smoking rate at one year — far exceeding nicotine patch outcomes. The compound also shows statistically significant associations with reduced partner violence and crime following a single dose, based on observational data.
  • •Mycelium vs. Fruit Body Potency: Mycelium expresses 10 to 100 times more genes than mushroom fruit bodies. When grown on rice substrate, mycelium biotransforms the grain into a fermented immunological product distinct from both the raw mycelium and the mushroom cap. Agaricon mycelium extract stored in 35% ethanol for 17 years retained full antiviral activity against COVID in vitro, demonstrating shelf stability and confirming that the active compounds are ethanol-soluble polyphenols — not beta-glucans, which precipitate above 25% alcohol concentration.
  • •H5N1 Pandemic Risk and Immune Preparedness: H5N1 bird flu has crossed into 90 mammal species and carries a 40–50% human fatality rate if sustained human transmission occurs — compared to COVID's sub-1% infection fatality rate in most populations. Stamets argues this threat justifies proactive immune upregulation using natural products rather than waiting for pathogen-specific vaccines. His team received a $2.6 million grant to screen 130 Agaricon strains for antiviral super-producers, modeled on the Mary Hunt cantaloupe discovery that enabled industrial penicillin production.

Notable Moment

Stamets turned down two requests to guide psilocybin sessions — one from his own father and one from the father of American mycology, Alexander Smith — not out of reluctance, but because neither man's spouse would participate. He concluded that facilitating the most profound experience of someone's life and then leaving them without a shared support partner risked damaging their most important relationship.

Know someone who'd find this useful?

Episode Transcript

I don't want to be alarmist, but COVID is not the last pandemic. In Washington State right now, two dairy farms are in quarantine because of H5N1, bird flu. Bird flu has jumped to ninety mammal species. 90. And the fatality rate of H5N1, if it hits humans, is about forty to fifty percent. That's gonna make COVID look like a minor viral pandemic. And this is something that we should all be concerned about. So this is why I believe in natural intelligence, upregulating natural immunity, because your sophisticated immune system has the wisdom to be able to create the antibodies to protect the host, the system, you and you are a natural product. Are you not? And natural products being used with each other is the lesson of evolution. Welcome to the Huberman Lab Podcast, where we discuss science and science based tools for everyday life. I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. My guest today is Paul Stamets. Paul Stamets is a mycologist, which means he studies fungi such as mushrooms and their applications for improving health and cognition. He is considered by many to be the father of modern applied mycology for studying and championing the use of specific fungi for improving immune function, cognition, tissue healing, and remodeling, including the brain, meaning brain plasticity and learning. Today's discussion starts with how to use mushrooms and other fungi to bolster your immune system. And it makes sense that you could use mushrooms to do so because they themselves have natural defense mechanisms against bacteria and viruses. We discussed the mechanisms by which that works and the particular mushrooms and other fungi that may work best for improving human immune system function and why. I want to point out that I have absolutely no financial relationship to Paul's company Host Defense, but during our conversation, I did ask him about specific mushroom strains and dosages and sources, because I'm curious about these things and their possible applications for myself. And I know many listeners and viewers of this podcast will be as well. We also talk extensively about the use of psilocybin, the data on micro dosing, as well as larger dosing of psilocybin for mental health, OCD, anxiety, and what the clinical studies are really showing. And I want to emphasize that of course we cover both the established benefits as well as what's unknown and of course the risks. And we discussed the use of non psychedelic mushrooms for increasing brain chemicals, such as brain derived nootrophic factor, which is one of the many key components of brain plasticity or learning. I have to say, I truly enjoyed this conversation with Paul Stamets. He is a very unique biologist. He's been focusing on an area of science that for many years was not considered fringe, but it had not yet been embraced by modern medicine. And now that modern medicine has started to embrace things like …

Get the full transcript (24,460 words) + summary by email — free

One-time email with the complete transcript and AI summary of this episode. No account needed.

One email, no spam. We’ll also show you what SignalCast does.

Browse all Huberman Lab transcripts →

You just read a 3-minute summary of a 145-minute episode.

Get Huberman Lab summarized like this every Monday — plus up to 2 more podcasts, free.

Pick Your Podcasts — Free

Keep Reading

More from Huberman Lab

We summarize every new episode. Want them in your inbox?

Similar Episodes

Related episodes from other podcasts

Explore Related Topics

This podcast is featured in Best Health Podcasts (2026) — ranked and reviewed with AI summaries.

Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.

You're clearly into Huberman Lab.

Every Monday, we deliver AI summaries of the latest episodes from Huberman Lab and 192+ other podcasts. Free for one show.

Start My Monday Digest

No credit card · Unsubscribe anytime